MitoRx Therapeutics

MitoRx Therapeutics is a pre-clinical stage rare disease biotech company aiming to become the leading global developer of medicines arresting the progression of degenerative diseases driven by mitochondrial dysfunction, with a focus on neuromuscular disease, metabolic disease and neurodegenerative disease

Mitochondrial disease,rare disease,duchenne,neuromuscular disease,dmd,biotech,preclinical,drug discovery,mitochondria,new class,mitorx,mtrx-1,hyperhomocysteinemia,huntington's,mitochondrial myopathy,muscular dystrophy,neurodegenerative disease,dementia,huntington's disease,cbs-deficiency,muscular dystrophy,first-in-class,and first-in-target

Mitorx therapeutics operates in the Biotechnology research industry.

Mitorx therapeutics's revenue is 11m - 100m

Mitorx therapeutics has 11 - 50 employees.